This proteomics study with new cohort validation identifies prostaglandin-H2 D-isomerase (PTGDS) as a potential early diagnostic biomarker for myocardial infarction (MI), including both ST-elevated MI (STEMI) and non–non-ST-elevated MI (NSTEMI). The gene discussed is PTGDS; the disease is myocardial infarction.